高级检索
当前位置: 首页 > 详情页

Subgroup analysis of first-line camrelizumab plus chemotherapy in brain metastases of NSCLC: Results from the CTONG 2003 trial

| 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangdong Acad Med Sci, Guangzhou, Peoples R China [2]Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Peoples R China [3]Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China [4]Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou, Peoples R China [5]Binzhou Med Univ Hosp, Yantai, Peoples R China [6]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China [7]Fujian Canc Hosp, Fuzhou, Peoples R China [8]Hebei Univ, Affiliated Hosp, Sch Clin Med, Baoding, Peoples R China [9]Zhejiang Univ, Affiliated Hangzhou Canc Hosp, Sch Med, Hangzhou, Peoples R China [10]Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Peoples R China [11]Nanchang Univ, Affiliated Hosp 2, Nanchang, Peoples R China [12]Southeast Univ, Zhongda Hosp, Nanjing, Peoples R China [13]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China [14]Huazhong Univ Sci & Technol, Hubei Canc Hosp, Tongji Med Coll, Wuhan, Peoples R China [15]Beijing Canc Hosp, Beijing, Peoples R China [16]Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China
出处:
ISSN:
基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2026]版:
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
JCR分区:
出版当年[2025]版:
最新[2023]版:
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子: 最新[2023版] 最新五年平均 出版当年[2025版] 出版当年五年平均 出版前一年[2024版]

第一作者:
第一作者机构: [1]Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangdong Acad Med Sci, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15355 今日访问量:0 总访问量:995 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号